6-31355013-T-C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_005514.8(HLA-B):c.1012+94A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000016 ( 0 hom., cov: 8)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
HLA-B
NM_005514.8 intron
NM_005514.8 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.45
Publications
38 publications found
Genes affected
HLA-B (HGNC:4932): (major histocompatibility complex, class I, B) HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008]
MIR6891 (HGNC:50243): (microRNA 6891) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000156 AC: 1AN: 63988Hom.: 0 Cov.: 8 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
63988
Hom.:
Cov.:
8
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 318578Hom.: 0 Cov.: 4 AF XY: 0.00 AC XY: 0AN XY: 168732
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
318578
Hom.:
Cov.:
4
AF XY:
AC XY:
0
AN XY:
168732
African (AFR)
AF:
AC:
0
AN:
7788
American (AMR)
AF:
AC:
0
AN:
16936
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
8418
East Asian (EAS)
AF:
AC:
0
AN:
15318
South Asian (SAS)
AF:
AC:
0
AN:
26316
European-Finnish (FIN)
AF:
AC:
0
AN:
22994
Middle Eastern (MID)
AF:
AC:
0
AN:
1270
European-Non Finnish (NFE)
AF:
AC:
0
AN:
203154
Other (OTH)
AF:
AC:
0
AN:
16384
GnomAD4 genome AF: 0.0000156 AC: 1AN: 63988Hom.: 0 Cov.: 8 AF XY: 0.0000328 AC XY: 1AN XY: 30502 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
1
AN:
63988
Hom.:
Cov.:
8
AF XY:
AC XY:
1
AN XY:
30502
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1
AN:
13078
American (AMR)
AF:
AC:
0
AN:
4784
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1758
East Asian (EAS)
AF:
AC:
0
AN:
2386
South Asian (SAS)
AF:
AC:
0
AN:
1186
European-Finnish (FIN)
AF:
AC:
0
AN:
4602
Middle Eastern (MID)
AF:
AC:
0
AN:
94
European-Non Finnish (NFE)
AF:
AC:
0
AN:
34890
Other (OTH)
AF:
AC:
0
AN:
702
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.